PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"31448846","Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study","Hermes G, Hyman SM, Fogelman N, Kosten TR, Sinha R.","Am J Addict. 2019 Nov;28(6):480-488. doi: 10.1111/ajad.12942. Epub 2019 Aug 26.","Hermes G","Am J Addict","2019","2019/08/27","","","10.1111/ajad.12942"
"31022027","New Drugs 2019, part 2","Hussar DA.","Nursing. 2019 May;49(5):32-41. doi: 10.1097/01.NURSE.0000554609.18148.78.","Hussar DA","Nursing","2019","2019/04/26","","","10.1097/01.NURSE.0000554609.18148.78"
"30874408","Lofexidine (Lucemyra) for Treatment of Opioid Withdrawal Symptoms","Bryce C.","Am Fam Physician. 2019 Mar 15;99(6):392-394.","Bryce C","Am Fam Physician","2019","2019/03/16","","",""
"30724094","Lofexidine: A Newly FDA-Approved, Nonopioid Treatment for Opioid Withdrawal","Doughty B, Morgenson D, Brooks T.","Ann Pharmacother. 2019 Jul;53(7):746-753. doi: 10.1177/1060028019828954. Epub 2019 Feb 6.","Doughty B","Ann Pharmacother","2019","2019/02/07","","","10.1177/1060028019828954"
"30580925","Baloxavir marboxil, Fremanezumab-vfrm, Galcanezumab-gnlm, and Lofexidine hydrochloride","Hussar DA, Moyer MR.","J Am Pharm Assoc (2003). 2019 Jan-Feb;59(1):141-144. doi: 10.1016/j.japh.2018.12.002. Epub 2018 Dec 21.","Hussar DA","J Am Pharm Assoc (2003)","2019","2018/12/25","","","10.1016/j.japh.2018.12.002"
"30379711","Drug updates and approvals: 2018 in review","Mospan C, Mospan G, Byland E, Whitaker WB, Xiong L, Dunlap J, Canupp K.","Nurse Pract. 2018 Dec;43(12):23-32. doi: 10.1097/01.NPR.0000547548.63764.6b.","Mospan C","Nurse Pract","2018","2018/11/01","","","10.1097/01.NPR.0000547548.63764.6b"
"30133422","Expanded table: Some drugs for management of opioid withdrawal symptoms","","Med Lett Drugs Ther. 2018 Aug 27;60(1554):e144-e146.","","Med Lett Drugs Ther","2018","2018/08/23","","",""
"30133420","Management of opioid withdrawal symptoms","","Med Lett Drugs Ther. 2018 Aug 27;60(1554):137-141.","","Med Lett Drugs Ther","2018","2018/08/23","","",""
"30036346","Lofexidine (Lucemyra) for opioid withdrawal","","Med Lett Drugs Ther. 2018 Jul 16;60(1551):115-117.","","Med Lett Drugs Ther","2018","2018/07/24","","",""
"29941528","FDA approves nonopioid medication for managing opioid withdrawal","Traynor K.","Am J Health Syst Pharm. 2018 Jul 1;75(13):927. doi: 10.2146/news180041.","Traynor K","Am J Health Syst Pharm","2018","2018/06/27","","","10.2146/news180041"
"29910009","Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore","Guo S, Manning V, Yang Y, Koh PK, Chan E, de Souza NN, Assam PN, Sultana R, Wijesinghe R, Pangjaya J, Kandasami G, Cheok C, Lee KM, Wong KE.","J Subst Abuse Treat. 2018 Aug;91:1-11. doi: 10.1016/j.jsat.2018.04.012. Epub 2018 Apr 25.","Guo S","J Subst Abuse Treat","2018","2018/06/19","","","10.1016/j.jsat.2018.04.012"
"29457671","Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder","Brezing CA, Choi CJ, Pavlicova M, Brooks D, Mahony AL, Mariani JJ, Levin FR.","Am J Addict. 2018 Mar;27(2):101-107. doi: 10.1111/ajad.12660. Epub 2018 Feb 19.","Brezing CA","Am J Addict","2018","2018/02/20","PMC5846101","NIHMS947333","10.1111/ajad.12660"
"28631527","Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals","Law FD, Diaper AM, Melichar JK, Coulton S, Nutt DJ, Myles JS.","J Psychopharmacol. 2017 Aug;31(8):1046-1055. doi: 10.1177/0269881117711710. Epub 2017 Jun 20.","Law FD","J Psychopharmacol","2017","2017/06/21","","","10.1177/0269881117711710"
"28553701","Opioid antagonists with minimal sedation for opioid withdrawal","Gowing L, Ali R, White JM.","Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4.","Gowing L","Cochrane Database Syst Rev","2017","2017/05/30","PMC6481395","","10.1002/14651858.CD002021.pub4"
"28527421","A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal","Gorodetzky CW, Walsh SL, Martin PR, Saxon AJ, Gullo KL, Biswas K.","Drug Alcohol Depend. 2017 Jul 1;176:79-88. doi: 10.1016/j.drugalcdep.2017.02.020. Epub 2017 May 10.","Gorodetzky CW","Drug Alcohol Depend","2017","2017/05/21","","","10.1016/j.drugalcdep.2017.02.020"
"28220474","Buprenorphine for managing opioid withdrawal","Gowing L, Ali R, White JM, Mbewe D.","Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.","Gowing L","Cochrane Database Syst Rev","2017","2017/02/22","PMC6464315","","10.1002/14651858.CD002025.pub5"
"27140827","Alpha₂-adrenergic agonists for the management of opioid withdrawal","Gowing L, Farrell M, Ali R, White JM.","Cochrane Database Syst Rev. 2016 May 3;2016(5):CD002024. doi: 10.1002/14651858.CD002024.pub5.","Gowing L","Cochrane Database Syst Rev","2016","2016/05/04","PMC7081129","","10.1002/14651858.CD002024.pub5"
"27124502","Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification","Vernon MK, Reinders S, Mannix S, Gullo K, Gorodetzky CW, Clinch T.","Addict Behav. 2016 Sep;60:109-16. doi: 10.1016/j.addbeh.2016.03.028. Epub 2016 Apr 1.","Vernon MK","Addict Behav","2016","2016/04/29","","","10.1016/j.addbeh.2016.03.028"
"26711160","Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial","Levin FR, Mariani JJ, Pavlicova M, Brooks D, Glass A, Mahony A, Nunes EV, Bisaga A, Dakwar E, Carpenter KM, Sullivan MA, Choi JC.","Drug Alcohol Depend. 2016 Feb 1;159:53-60. doi: 10.1016/j.drugalcdep.2015.11.025. Epub 2015 Nov 27.","Levin FR","Drug Alcohol Depend","2016","2015/12/30","PMC4729291","NIHMS746664","10.1016/j.drugalcdep.2015.11.025"
"25260380","The preclinical discovery of lofexidine for the treatment of opiate addiction","Vartak AP.","Expert Opin Drug Discov. 2014 Nov;9(11):1371-7. doi: 10.1517/17460441.2014.962995. Epub 2014 Sep 26.","Vartak AP","Expert Opin Drug Discov","2014","2014/09/28","","","10.1517/17460441.2014.962995"
"24906134","Dual effects of α2 -adrenoceptors in modulating myogenic tone in sheep isolated internal anal sphincter","Rayment SJ, Simpson JA, Eames T, Acheson AG, Dashwood MR, Henry Y, Gruss H, Scholefield JH, Wilson VG.","Neurogastroenterol Motil. 2014 Aug;26(8):1095-103. doi: 10.1111/nmo.12363. Epub 2014 Jun 6.","Rayment SJ","Neurogastroenterol Motil","2014","2014/06/07","","","10.1111/nmo.12363"
"24595586","Non-surgical interventions for the management of chronic pelvic pain","Cheong YC, Smotra G, Williams AC.","Cochrane Database Syst Rev. 2014 Mar 5;(3):CD008797. doi: 10.1002/14651858.CD008797.pub2.","Cheong YC","Cochrane Database Syst Rev","2014","2014/03/06","","","10.1002/14651858.CD008797.pub2"
"24316175","Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine","De La Garza R 2nd, Galloway GP, Newton TF, Mendelson J, Haile CN, Dib E, Hawkins RY, Chen CY, Mahoney JJ 3rd, Mojsiak J, Lao G, Anderson A, Kahn R.","Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:44-52. doi: 10.1016/j.pnpbp.2013.11.013. Epub 2013 Dec 4.","De La Garza R 2nd","Prog Neuropsychopharmacol Biol Psychiatry","2014","2013/12/10","PMC4562471","NIHMS552190","10.1016/j.pnpbp.2013.11.013"
"23998378","Differential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys","Kohut SJ, Fivel PA, Mello NK.","Drug Alcohol Depend. 2013 Dec 1;133(2):593-9. doi: 10.1016/j.drugalcdep.2013.07.032. Epub 2013 Aug 11.","Kohut SJ","Drug Alcohol Depend","2013","2013/09/04","PMC3818349","NIHMS514758","10.1016/j.drugalcdep.2013.07.032"
"23062049","Opioid dependence","Praveen KT, Law F, O'Shea J, Melichar J.","Am Fam Physician. 2012 Sep 15;86(6):565-6.","Praveen KT","Am Fam Physician","2012","2012/10/16","","",""
"21036514","Outpatient versus inpatient opioid detoxification: a randomized controlled trial","Day E, Strang J.","J Subst Abuse Treat. 2011 Jan;40(1):56-66. doi: 10.1016/j.jsat.2010.08.007. Epub 2010 Oct 30.","Day E","J Subst Abuse Treat","2011","2010/11/02","","","10.1016/j.jsat.2010.08.007"
"20169438","The pharmacological treatment of opioid addiction--a clinical perspective","Lobmaier P, Gossop M, Waal H, Bramness J.","Eur J Clin Pharmacol. 2010 Jun;66(6):537-45. doi: 10.1007/s00228-010-0793-6. Epub 2010 Feb 19.","Lobmaier P","Eur J Clin Pharmacol","2010","2010/02/20","","","10.1007/s00228-010-0793-6"
"20074867","A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis","Meader N.","Drug Alcohol Depend. 2010 Apr 1;108(1-2):110-4. doi: 10.1016/j.drugalcdep.2009.12.008. Epub 2010 Jan 13.","Meader N","Drug Alcohol Depend","2010","2010/01/16","","","10.1016/j.drugalcdep.2009.12.008"
"20040696","Lofexidine, an {alpha}2-receptor agonist for opioid detoxification","Gish EC, Miller JL, Honey BL, Johnson PN.","Ann Pharmacother. 2010 Feb;44(2):343-51. doi: 10.1345/aph.1M347. Epub 2009 Dec 29.","Gish EC","Ann Pharmacother","2010","2009/12/31","","","10.1345/aph.1M347"
"20014908","A study on Fu-Yuan Pellet, a traditional chinese medicine formula for detoxification of heroin addictions","Wang X, Li J, Huang M, Kang L, Hu M.","Am J Drug Alcohol Abuse. 2009;35(6):408-11. doi: 10.3109/00952990903377146.","Wang X","Am J Drug Alcohol Abuse","2009","2009/12/18","","","10.3109/00952990903377146"
"19637105","Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patients","Al Ghananeem AM, Herman BH, Abbassi M, Yu E, Miotto K, O'Brien CP, Ling W, Montgomery A, Walsh R.","Am J Drug Alcohol Abuse. 2009;35(5):311-5. doi: 10.1080/00952990903060135.","Al Ghananeem AM","Am J Drug Alcohol Abuse","2009","2009/07/29","","","10.1080/00952990903060135"
"19588330","Buprenorphine for the management of opioid withdrawal","Gowing L, Ali R, White JM.","Cochrane Database Syst Rev. 2009 Jul 8;(3):CD002025. doi: 10.1002/14651858.CD002025.pub4.","Gowing L","Cochrane Database Syst Rev","2009","2009/07/10","","","10.1002/14651858.CD002025.pub4"
"19397459","Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study","Schmittner J, Schroeder JR, Epstein DH, Krantz MJ, Eid NC, Preston KL.","Pharmacotherapy. 2009 May;29(5):495-502. doi: 10.1592/phco.29.5.495.","Schmittner J","Pharmacotherapy","2009","2009/04/29","PMC3150470","NIHMS312570","10.1592/phco.29.5.495"
"19016185","A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms","Shi J, Xu GZ, Liu TT, Wang X, Shen LY, Li J, Hao W, Chen HX, Li SX, Lu L.","Am J Drug Alcohol Abuse. 2008;34(6):792-800. doi: 10.1080/00952990802491563.","Shi J","Am J Drug Alcohol Abuse","2008","2008/11/19","","","10.1080/00952990802491563"
"18821454","Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis","Yu E, Miotto K, Akerele E, O'Brien CP, Ling W, Kleber H, Fischman MW, Elkashef A, Herman BH, Al-Ghananeem AM.","Am J Drug Alcohol Abuse. 2008;34(5):611-6. doi: 10.1080/00952990802308122.","Yu E","Am J Drug Alcohol Abuse","2008","2008/09/30","","","10.1080/00952990802308122"
"18508207","A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal","Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, Montoya I, Fischman MW, Collins J, McSherry F, Boardman K, Davies DK, O'Brien CP, Ling W, Kleber H, Herman BH.","Drug Alcohol Depend. 2008 Sep 1;97(1-2):158-68. doi: 10.1016/j.drugalcdep.2008.04.002. Epub 2008 May 27.","Yu E","Drug Alcohol Depend","2008","2008/05/30","PMC2613766","NIHMS61453","10.1016/j.drugalcdep.2008.04.002"
"18428069","Tai-Kang-Ning, a Chinese herbal medicine formula, alleviates acute heroin withdrawal","Kang L, Li B, Gao L, Li S, Wang D, Hu M, Li J.","Am J Drug Alcohol Abuse. 2008;34(3):269-76. doi: 10.1080/00952990802013409.","Kang L","Am J Drug Alcohol Abuse","2008","2008/04/23","","","10.1080/00952990802013409"
"18393298","Pharmacokinetics of lofexidine hydrochloride in healthy volunteers","Al-Ghananeem AM.","J Pharm Sci. 2009 Jan;98(1):319-26. doi: 10.1002/jps.21401.","Al-Ghananeem AM","J Pharm Sci","2009","2008/04/09","","","10.1002/jps.21401"
"18161012","Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Foltin RW.","Psychopharmacology (Berl). 2008 Mar;197(1):157-68. doi: 10.1007/s00213-007-1020-8. Epub 2007 Dec 27.","Haney M","Psychopharmacology (Berl)","2008","2007/12/28","PMC3372576","NIHMS366969","10.1007/s00213-007-1020-8"
"17655511","Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study","Schroeder JR, Schmittner J, Bleiberg J, Epstein DH, Krantz MJ, Preston KL.","Pharmacotherapy. 2007 Aug;27(8):1111-9. doi: 10.1592/phco.27.8.1111.","Schroeder JR","Pharmacotherapy","2007","2007/07/28","","","10.1592/phco.27.8.1111"
"17136399","Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings","Sinha R, Kimmerling A, Doebrick C, Kosten TR.","Psychopharmacology (Berl). 2007 Mar;190(4):569-74. doi: 10.1007/s00213-006-0640-8. Epub 2006 Nov 29.","Sinha R","Psychopharmacology (Berl)","2007","2006/12/01","","","10.1007/s00213-006-0640-8"
"17064857","In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone","McCambridge J, Gossop M, Beswick T, Best D, Bearn J, Rees S, Strang J.","Drug Alcohol Depend. 2007 Apr 17;88(1):91-5. doi: 10.1016/j.drugalcdep.2006.09.020. Epub 2006 Oct 24.","McCambridge J","Drug Alcohol Depend","2007","2006/10/27","","","10.1016/j.drugalcdep.2006.09.020"
"16669899","Opiate addiction in China: current situation and treatments","Tang YL, Zhao D, Zhao C, Cubells JF.","Addiction. 2006 May;101(5):657-65. doi: 10.1111/j.1360-0443.2006.01367.x.","Tang YL","Addiction","2006","2006/05/04","","","10.1111/j.1360-0443.2006.01367.x"
"16437438","Opioid antagonists with minimal sedation for opioid withdrawal","Gowing L, Ali R, White J.","Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002021. doi: 10.1002/14651858.CD002021.pub2.","Gowing L","Cochrane Database Syst Rev","2006","2006/01/27","","","10.1002/14651858.CD002021.pub2"
"16367987","A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial","Raistrick D, West D, Finnegan O, Thistlethwaite G, Brearley R, Banbery J.","Addiction. 2005 Dec;100(12):1860-7. doi: 10.1111/j.1360-0443.2005.01273.x.","Raistrick D","Addiction","2005","2005/12/22","","","10.1111/j.1360-0443.2005.01273.x"
"16191667","Induction of patients with moderately severe methadone dependence onto buprenorphine","Glasper A, Reed LJ, de Wet CJ, Gossop M, Bearn J.","Addict Biol. 2005 Jun;10(2):149-55. doi: 10.1080/13556210500123126.","Glasper A","Addict Biol","2005","2005/09/30","","","10.1080/13556210500123126"
"15551068","Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats","Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y.","Psychopharmacology (Berl). 2005 May;179(2):366-73. doi: 10.1007/s00213-004-2036-y. Epub 2004 Nov 17.","Lê AD","Psychopharmacology (Berl)","2005","2004/11/20","","","10.1007/s00213-004-2036-y"
"15528619","QT interval increased after single dose of lofexidine","Schmittner J, Schroeder JR, Epstein DH, Preston KL.","BMJ. 2004 Nov 6;329(7474):1075. doi: 10.1136/bmj.329.7474.1075.","Schmittner J","BMJ","2004","2004/11/06","PMC526119","","10.1136/bmj.329.7474.1075"
"15074088","[Clinical observation on effect of modified banxia houpu decoction in treating patients with protracted heroin abstinence syndrome]","Huang DB, Yu ZF, Fu L.","Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Mar;24(3):216-9.","Huang DB","Zhongguo Zhong Xi Yi Jie He Za Zhi","2004","2004/04/13","","",""
"14504022","The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial","Beswick T, Best D, Bearn J, Gossop M, Rees S, Strang J.","Am J Addict. 2003 Jul-Sep;12(4):295-305.","Beswick T","Am J Addict","2003","2003/09/25","","",""
"12745416","Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments","Beswick T, Best D, Rees S, Bearn J, Gossop M, Strang J.","Addict Biol. 2003 Mar;8(1):49-57. doi: 10.1080/1355621031000069882.","Beswick T","Addict Biol","2003","2003/05/15","","","10.1080/1355621031000069882"
"12680748","A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","Niederhofer H, Staffen W, Mair A.","J Psychopharmacol. 2003 Mar;17(1):113-9. doi: 10.1177/0269881103017001714.","Niederhofer H","J Psychopharmacol","2003","2003/04/12","","","10.1177/0269881103017001714"
"12653813","Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans","Walsh SL, Strain EC, Bigelow GE.","Addiction. 2003 Apr;98(4):427-39. doi: 10.1046/j.1360-0443.2003.00372.x.","Walsh SL","Addiction","2003","2003/03/26","","","10.1046/j.1360-0443.2003.00372.x"
"12447025","Lofexidine in hyperactive and impulsive children with autistic disorder","Niederhofer H, Staffen W, Mair A.","J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1396-7. doi: 10.1097/00004583-200212000-00010.","Niederhofer H","J Am Acad Child Adolesc Psychiatry","2002","2002/11/26","","","10.1097/00004583-200212000-00010"
"12095666","Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone","Howells C, Allen S, Gupta J, Stillwell G, Marsden J, Farrell M.","Drug Alcohol Depend. 2002 Jul 1;67(2):169-76. doi: 10.1016/s0376-8716(02)00024-8.","Howells C","Drug Alcohol Depend","2002","2002/07/04","","","10.1016/s0376-8716(02)00024-8"
"11895270","Alpha2-adrenergic agonists in opioid withdrawal","Gowing LR, Farrell M, Ali RL, White JM.","Addiction. 2002 Jan;97(1):49-58. doi: 10.1046/j.1360-0443.2002.00037.x.","Gowing LR","Addiction","2002","2002/03/16","","","10.1046/j.1360-0443.2002.00037.x"
"11795622","Use of qigong therapy in the detoxification of heroin addicts","Li M, Chen K, Mo Z.","Altern Ther Health Med. 2002 Jan-Feb;8(1):50-4, 56-9.","Li M","Altern Ther Health Med","2002","2002/01/25","","",""
"11714592","Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine","White R, Alcorn R, Feinmann C.","Drug Alcohol Depend. 2001 Dec 1;65(1):77-83. doi: 10.1016/s0376-8716(01)00149-1.","White R","Drug Alcohol Depend","2001","2001/11/21","","","10.1016/s0376-8716(01)00149-1"
"11582998","[Therapy of tic disorders apparently of organic origin in a multi-morbid 5-year-old patient with lofexidine (Britlofex) and clonidine (Catapressan)]","Niederhofer H.","Wien Med Wochenschr. 2001;151(13-14):327-8.","Niederhofer H","Wien Med Wochenschr","2001","2001/10/05","","",""
"11524309","A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide","Keaney F, Strang J, Gossop M, Marshall EJ, Farrell M, Welch S, Hahn B, Gonzalez A.","Alcohol Alcohol. 2001 Sep-Oct;36(5):426-30. doi: 10.1093/alcalc/36.5.426.","Keaney F","Alcohol Alcohol","2001","2001/08/29","","","10.1093/alcalc/36.5.426"
"11522461","Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats","Highfield D, Yap J, Grimm JW, Shalev U, Shaham Y.","Neuropsychopharmacology. 2001 Sep;25(3):320-31. doi: 10.1016/S0893-133X(01)00227-5.","Highfield D","Neuropsychopharmacology","2001","2001/08/28","","","10.1016/S0893-133X(01)00227-5"
"11516922","Lofexidine versus clonidine in rapid opiate detoxification","Gerra G, Zaimovic A, Giusti F, Di Gennaro C, Zambelli U, Gardini S, Delsignore R.","J Subst Abuse Treat. 2001 Jul;21(1):11-7. doi: 10.1016/s0740-5472(01)00178-7.","Gerra G","J Subst Abuse Treat","2001","2001/08/23","","","10.1016/s0740-5472(01)00178-7"
"11473971","Randomized placebo controlled trial of lofexidine hydrochloride for chronic pelvic pain in women","Stones RW, Bradbury L, Anderson D.","Hum Reprod. 2001 Aug;16(8):1719-21. doi: 10.1093/humrep/16.8.1719.","Stones RW","Hum Reprod","2001","2001/07/28","","","10.1093/humrep/16.8.1719"
"11210198","Addiction pharmacotherapy 2000: new options, new challenges","Rawson RA, McCann MJ, Hasson AJ, Ling W.","J Psychoactive Drugs. 2000 Oct-Dec;32(4):371-8. doi: 10.1080/02791072.2000.10400238.","Rawson RA","J Psychoactive Drugs","2000","2001/02/24","","","10.1080/02791072.2000.10400238"
"10891632","Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification","Buntwal N, Bearn J, Gossop M, Strang J.","Drug Alcohol Depend. 2000 May 1;59(2):183-8. doi: 10.1016/s0376-8716(99)00116-7.","Buntwal N","Drug Alcohol Depend","2000","2000/07/13","","","10.1016/s0376-8716(99)00116-7"
"10882840","Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking","Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J.","Neuropsychopharmacology. 2000 Aug;23(2):138-50. doi: 10.1016/S0893-133X(99)00158-X.","Erb S","Neuropsychopharmacology","2000","2000/07/07","","","10.1016/S0893-133X(99)00158-X"
"10598217","Lofexidine for opiate detoxification: review of recent randomised and open controlled trials","Strang J, Bearn J, Gossop M.","Am J Addict. 1999 Fall;8(4):337-48. doi: 10.1080/105504999305749.","Strang J","Am J Addict","1999","1999/12/22","","","10.1080/105504999305749"
"10441888","An addict who wants to detoxify","Smith P, Gerada C, Kemp K.","Practitioner. 1998 Nov;242(1592):735-6, 739-40.","Smith P","Practitioner","1998","1999/08/12","","",""
"10085500","The use of lofexidine by drug dependency units in the United Kingdom","Akhurst JS.","Eur Addict Res. 1999 Mar;5(1):43-9. doi: 10.1159/000018962.","Akhurst JS","Eur Addict Res","1999","1999/03/23","","","10.1159/000018962"
"9649979","Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal","Carnwath T, Hardman J.","Drug Alcohol Depend. 1998 May 1;50(3):251-4. doi: 10.1016/s0376-8716(98)00040-4.","Carnwath T","Drug Alcohol Depend","1998","1998/07/03","","","10.1016/s0376-8716(98)00040-4"
"9649976","Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification","Bearn J, Gossop M, Strang J.","Drug Alcohol Depend. 1998 May 1;50(3):227-32. doi: 10.1016/s0376-8716(98)00030-1.","Bearn J","Drug Alcohol Depend","1998","1998/07/03","","","10.1016/s0376-8716(98)00030-1"
"9584973","A naturalistic study of home detoxification from opiates using lofexidine","Brown AS, Fleming PM.","J Psychopharmacol. 1998;12(1):93-6. doi: 10.1177/026988119801200112.","Brown AS","J Psychopharmacol","1998","1998/05/19","","","10.1177/026988119801200112"
"9363412","Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal","Lin SK, Strang J, Su LW, Tsai CJ, Hu WH.","Drug Alcohol Depend. 1997 Nov 25;48(2):127-33. doi: 10.1016/s0376-8716(97)00116-6.","Lin SK","Drug Alcohol Depend","1997","1997/11/18","","","10.1016/s0376-8716(97)00116-6"
"9031821","Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital","Kahn A, Mumford JP, Rogers GA, Beckford H.","Drug Alcohol Depend. 1997 Jan 10;44(1):57-61. doi: 10.1016/s0376-8716(96)01316-6.","Kahn A","Drug Alcohol Depend","1997","1997/01/10","","","10.1016/s0376-8716(96)01316-6"
"8957147","Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal","Bearn J, Gossop M, Strang J.","Drug Alcohol Depend. 1996 Dec 2;43(1-2):87-91. doi: 10.1016/s0376-8716(96)01289-6.","Bearn J","Drug Alcohol Depend","1996","1996/12/02","","","10.1016/s0376-8716(96)01289-6"
"8598706","What is important in drug misuse treatment?","Seivewright NA, Greenwood J.","Lancet. 1996 Feb 10;347(8998):373-6. doi: 10.1016/s0140-6736(96)90542-5.","Seivewright NA","Lancet","1996","1996/02/10","","","10.1016/s0140-6736(96)90542-5"
"7760607","Lofexidine and opioid withdrawal","Cox S, Alcorn R.","Lancet. 1995 Jun 3;345(8962):1385-6. doi: 10.1016/s0140-6736(95)92593-7.","Cox S","Lancet","1995","1995/06/03","","","10.1016/s0140-6736(95)92593-7"
"7612327","Lofexidine based regimen for opiate addicts","Wylie AS, Stewart AM.","Br J Gen Pract. 1995 Apr;45(393):217-8.","Wylie AS","Br J Gen Pract","1995","1995/04/01","PMC1239207","",""
"7496663","Clozapine-induced hypersalivation and the alpha 2 adrenoceptor","Corrigan FM, MacDonald S, Reynolds GP.","Br J Psychiatry. 1995 Sep;167(3):412. doi: 10.1192/bjp.167.3.412a.","Corrigan FM","Br J Psychiatry","1995","1995/09/01","","","10.1192/bjp.167.3.412a"
"7471616","Early hemodynamic and humoral effects of lofexidine","Fouad FM, Vidt DG, Williams H, Tarazi RC, Bravo EL.","Clin Pharmacol Ther. 1981 Apr;29(4):498-504. doi: 10.1038/clpt.1981.69.","Fouad FM","Clin Pharmacol Ther","1981","1981/04/01","","","10.1038/clpt.1981.69"
"7338185","Opiate detoxification with lofexidine","Gold MS, Pottash AC, Sweeney DR, Extein I, Annitto WJ.","Drug Alcohol Depend. 1981 Dec;8(4):307-15. doi: 10.1016/0376-8716(81)90040-5.","Gold MS","Drug Alcohol Depend","1981","1981/12/01","","","10.1016/0376-8716(81)90040-5"
"7229119","Centrally acting antihypertensive agents: a comparison of lofexidine with clonidine","Schultz HS, Chretien SD, Brewer DD, Eltorai MI, Weber MA.","J Clin Pharmacol. 1981 Feb-Mar;21(2):65-71. doi: 10.1002/j.1552-4604.1981.tb01751.x.","Schultz HS","J Clin Pharmacol","1981","1981/02/01","","","10.1002/j.1552-4604.1981.tb01751.x"
"7217339","Nonnarcotic antidiarrheal action of clonidine and lofexidine in the rat","Lal H, Shearman GT, Ursillo RC.","J Clin Pharmacol. 1981 Jan;21(1):16-9. doi: 10.1002/j.1552-4604.1981.tb01726.x.","Lal H","J Clin Pharmacol","1981","1981/01/01","","","10.1002/j.1552-4604.1981.tb01726.x"
"7190295","Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat","Shearman GT, Lal H, Ursillo RC.","Pharmacol Biochem Behav. 1980 Apr;12(4):573-5. doi: 10.1016/0091-3057(80)90191-4.","Shearman GT","Pharmacol Biochem Behav","1980","1980/04/01","","","10.1016/0091-3057(80)90191-4"
"7156295","Lofexidine in abrupt methadone withdrawal","Washton AM, Resnick RB.","Psychopharmacol Bull. 1982 Oct;18(4):220-1.","Washton AM","Psychopharmacol Bull","1982","1982/10/01","","",""
"7059442","Antihypertensive effects of lofexidine in patients with essential hypertension","Fagan TC, Bloomfield SS, Cowart TD, Corns-Hurwitz RH, Lipicky RJ, Conradi EC, Hsu CY, Grossman WJ, Harmon GE, Degenhart WJ, Sinkfield AW, Gaffney TE.","Br J Clin Pharmacol. 1982 Mar;13(3):405-10. doi: 10.1111/j.1365-2125.1982.tb01393.x.","Fagan TC","Br J Clin Pharmacol","1982","1982/03/01","PMC1402104","","10.1111/j.1365-2125.1982.tb01393.x"
"7030578","Lofexidine and clonidine in moderate essential hypertension","Wilkins LH, Winternitz SR, Oparil S, Smith LR, Dustan HP.","Clin Pharmacol Ther. 1981 Dec;30(6):752-07. doi: 10.1038/clpt.1981.234.","Wilkins LH","Clin Pharmacol Ther","1981","1981/12/01","","","10.1038/clpt.1981.234"
"7016930","Lofexidine in the treatment of hypertension: a twice-daily versus one-daily dose comparison with 24-hour blood pressure monitoring","Garrett BN, Kaplan NM.","J Clin Pharmacol. 1981 Apr;21(4):173-80. doi: 10.1002/j.1552-4604.1981.tb05697.x.","Garrett BN","J Clin Pharmacol","1981","1981/04/01","","","10.1002/j.1552-4604.1981.tb05697.x"
"6890374","Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects","Dollery CT, Reid JL.","Arzneimittelforschung. 1982;32(8a):984-7.","Dollery CT","Arzneimittelforschung","1982","1982/01/01","","",""
"6890373","Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide","Aigner A, Schmidt U.","Arzneimittelforschung. 1982;32(8a):976-83.","Aigner A","Arzneimittelforschung","1982","1982/01/01","","",""
"6890372","The absorption and excretion of 14C-lofexidine hydrochloride in man","Midgley I, Chasseaud LF, Taylor T, Darragh A.","Arzneimittelforschung. 1982;32(8a):972-5.","Midgley I","Arzneimittelforschung","1982","1982/01/01","","",""
"6890371","Toxicology of the combination lofexidine/hydrochlorothiazide","Friehe H, Fontaine R, Gibson JP, Larson EJ, Sells DM.","Arzneimittelforschung. 1982;32(8a):966-71.","Friehe H","Arzneimittelforschung","1982","1982/01/01","","",""
"6890370","Teratologic and reproductive studies of lofexidine","Tsai TH, Beitman RE, Gibson JP, Larson EJ.","Arzneimittelforschung. 1982;32(8a):962-6.","Tsai TH","Arzneimittelforschung","1982","1982/01/01","","",""
"6890369","Acute, subacute and chronic toxicity/Carcinogenicity of lofexidine","Tsai TH, Beitman RE, Gibson JP, Larson EJ, Friehe H, Fontaine R.","Arzneimittelforschung. 1982;32(8a):955-62.","Tsai TH","Arzneimittelforschung","1982","1982/01/01","","",""
"6890368","Animal experiments on the cardiovascular effects of lofexidine","Graf E, Doppelfeld IS, Prop G.","Arzneimittelforschung. 1982;32(8a):941-55.","Graf E","Arzneimittelforschung","1982","1982/01/01","","",""
"6890367","Animal experiments on the safety pharmacology of lofexidine","Graf E, Sieck A, Wenzl H, Winkelmann J.","Arzneimittelforschung. 1982;32(8a):931-40.","Graf E","Arzneimittelforschung","1982","1982/01/01","","",""
"6890366","Actions of lofexidine on isolated heart and smooth muscle preparations","Graf E.","Arzneimittelforschung. 1982;32(8a):923-30.","Graf E","Arzneimittelforschung","1982","1982/01/01","","",""
"6890365","Characteristics of lofexidine in pharmacological screening","Wagener HH, Genthe H.","Arzneimittelforschung. 1982;32(8a):918-23.","Wagener HH","Arzneimittelforschung","1982","1982/01/01","","",""
"6890364","Chemistry of lofexidine","Betzing H, Biedermann J.","Arzneimittelforschung. 1982;32(8a):916-8.","Betzing H","Arzneimittelforschung","1982","1982/01/01","","",""
"6880242","Biotransformation of lofexidine in humans","Midgley I, Fowkes AG, Chasseaud LF, Hawkins DR, Girkin R, Kesselring K.","Xenobiotica. 1983 Feb;13(2):87-95. doi: 10.3109/00498258309052241.","Midgley I","Xenobiotica","1983","1983/02/01","","","10.3109/00498258309052241"
"6865916","Identification of 2-imidazolines as anti-sickling agents","Chang H, Ewert SM, Nagel RL.","Mol Pharmacol. 1983 May;23(3):731-4.","Chang H","Mol Pharmacol","1983","1983/05/01","","",""
"6811917","Lofexidine blocks acute opiate withdrawal","Gold MS, Pottash AC, Sweeney DR, Extein I, Annitto WJ.","NIDA Res Monogr. 1982 Apr;41:264-8.","Gold MS","NIDA Res Monogr","1982","1982/04/01","","",""
"6811916","Opiate detoxification using lofexidine","Washton AM, Resnick RB, Perzel JF, Garwood J.","NIDA Res Monogr. 1982 Apr;41:261-3.","Washton AM","NIDA Res Monogr","1982","1982/04/01","","",""
"6765486","Clonidine in opiate withdrawal: review and appraisal of clinical findings","Washton AM, Resnick RB.","Pharmacotherapy. 1981 Sep-Oct;1(2):140-6. doi: 10.1002/j.1875-9114.1981.tb03561.x.","Washton AM","Pharmacotherapy","1981","1981/09/01","","","10.1002/j.1875-9114.1981.tb03561.x"
"6753858","Comparative efficacy and safety of lofexidine and clonidine given alone or concomitantly with hydrochlorothiazide in hypertensive outpatients","Beitman RE, Kuzma RJ, McMahon FG, Morledge J, Mroczek W, Rolf CN, Tsai TH.","Arzneimittelforschung. 1982;32(8a):988-93.","Beitman RE","Arzneimittelforschung","1982","1982/01/01","","",""
"6702628","Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension","Lopez LM, Mehta JL.","Am J Cardiol. 1984 Mar 1;53(6):787-90. doi: 10.1016/0002-9149(84)90405-3.","Lopez LM","Am J Cardiol","1984","1984/03/01","","","10.1016/0002-9149(84)90405-3"
"6451166","Platelet function in hypertension and effect of therapy","Mehta J, Mehta P.","Am J Cardiol. 1981 Feb;47(2):331-4. doi: 10.1016/0002-9149(81)90405-7.","Mehta J","Am J Cardiol","1981","1981/02/01","","","10.1016/0002-9149(81)90405-7"
"6410276","Recent advances in opiate detoxification: clonidine and lofexidine","Washton AM, Resnick RB.","NIDA Res Monogr. 1983 Apr;43:44-50.","Washton AM","NIDA Res Monogr","1983","1983/04/01","","",""
"6388273","The sequential use of clonidine and naltrexone in the treatment of opiate addicts","Gold MS, Dackis CA, Washton AM.","Adv Alcohol Subst Abuse. 1984 Spring;3(3):19-39. doi: 10.1300/J251v03n03_03.","Gold MS","Adv Alcohol Subst Abuse","1984","1984/01/01","","","10.1300/J251v03n03_03"
"6357591","Hemodynamic effect of lofexidine with a diuretic in hypertension","Vlachakis ND, Velasquez M, Alexander N, Maronde RF.","Clin Pharmacol Ther. 1983 Dec;34(6):764-9. doi: 10.1038/clpt.1983.247.","Vlachakis ND","Clin Pharmacol Ther","1983","1983/12/01","","","10.1038/clpt.1983.247"
"6355070","Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects","Washton AM, Resnick RB, Geyer G.","J Clin Psychiatry. 1983 Sep;44(9):335-7.","Washton AM","J Clin Psychiatry","1983","1983/09/01","","",""
"6303236","Binding of (+/-)-3H-lofexidine to alpha-adrenoceptors in membranes from rat brain","Timmermans PB, van Kemenade JE, Harms YM, Prop G, Graf E, van Zwieten PA.","Arch Int Pharmacodyn Ther. 1983 Jan;261(1):23-35.","Timmermans PB","Arch Int Pharmacodyn Ther","1983","1983/01/01","","",""
"6255379","Selectivity of a series of clonidine-like drugs for alpha 1 and alpha 2 adrenoceptors in rat brain","Summers RJ, Jarrott B, Louis WJ.","Neurosci Lett. 1980 Dec;20(3):347-50. doi: 10.1016/0304-3940(80)90172-x.","Summers RJ","Neurosci Lett","1980","1980/12/01","","","10.1016/0304-3940(80)90172-x"
"6129948","Characterization of central alpha-adrenoceptors using 3H-clonidine and its derivatives","Jarrott B, Louis WJ, Summers RJ.","Chest. 1983 Feb;83(2 Suppl):339-40.","Jarrott B","Chest","1983","1983/02/01","","",""
"6112397","Lofexidine, a clonidine analogue effective in opiate withdrawal","","Lancet. 1981 May 2;1(8227):991-2.","","Lancet","1981","1981/05/02","","",""
"6090812","Blind study of the effect of the alpha-adrenergic agonists clonidine and lofexidine on alcohol withdrawal in the rat","Hemmingsen R, Clemmesen L, Barry DI.","J Stud Alcohol. 1984 Jul;45(4):310-5. doi: 10.15288/jsa.1984.45.310.","Hemmingsen R","J Stud Alcohol","1984","1984/07/01","","","10.15288/jsa.1984.45.310"
"4082462","Investigation of clonidine and lofexidine for the treatment of barbiturate withdrawal in mice","Siegel EG, Bonfiglio JF, Ritschel WA, Fant W.","Vet Hum Toxicol. 1985 Dec;27(6):503-5.","Siegel EG","Vet Hum Toxicol","1985","1985/12/01","","",""
"4033447","A preliminary evaluation of the effect of lofexidine on vasomotor flushes in post-menopausal women","Jones KP, Ravnikar V, Schiff I.","Maturitas. 1985 Jul;7(2):135-9. doi: 10.1016/0378-5122(85)90019-2.","Jones KP","Maturitas","1985","1985/07/01","","","10.1016/0378-5122(85)90019-2"
"3910387","Long-term experience with lofexidine in the treatment of mild-to-moderate essential hypertension","Lopez LM, Mehta JL.","Drug Intell Clin Pharm. 1985 Dec;19(12):928-32. doi: 10.1177/106002808501901214.","Lopez LM","Drug Intell Clin Pharm","1985","1985/12/01","","","10.1177/106002808501901214"
"3890587","Alcohol withdrawal syndromes: clinical management with lofexidine","Cushman P Jr, Forbes R, Lerner W, Stewart M.","Alcohol Clin Exp Res. 1985 Mar-Apr;9(2):103-8. doi: 10.1111/j.1530-0277.1985.tb05527.x.","Cushman P Jr","Alcohol Clin Exp Res","1985","1985/03/01","","","10.1111/j.1530-0277.1985.tb05527.x"
"3741551","Lofexidine in alcohol withdrawal states","Brunning J, Mumford JP, Keaney FP.","Alcohol Alcohol. 1986;21(2):167-70.","Brunning J","Alcohol Alcohol","1986","1986/01/01","","",""
"3529831","Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory","Agren H.","Acta Psychiatr Scand Suppl. 1986;327:91-113.","Agren H","Acta Psychiatr Scand Suppl","1986","1986/01/01","","",""
"3200516","Behavioral evaluation of rats prenatally exposed to the adrenergic agonists clonidine and lofexidine","Pizzi WJ, Ali SF, Holson RR.","Neurotoxicology. 1988 Fall;9(3):559-66.","Pizzi WJ","Neurotoxicology","1988","1988/01/01","","",""
"2988468","Interference of enantiomers of lofexidine with alpha-adrenoceptors","Wilffert B, Mathy MJ, Batink HD, de Jonge A, Thoolen MJ, Prop G, Graf E, Timmermans PB, van Zwieten PA.","Arch Int Pharmacodyn Ther. 1985 Jan;273(1):18-32.","Wilffert B","Arch Int Pharmacodyn Ther","1985","1985/01/01","","",""
"2904669","Neurochemical evaluation of rats prenatally exposed to the adrenergic agonists clonidine and lofexidine","Ali SF, Holson RR, Pizzi WJ, Newport GD, Slikker W Jr.","Neurotoxicology. 1988 Fall;9(3):551-7.","Ali SF","Neurotoxicology","1988","1988/01/01","","",""
"2893930","Another trial that failed","Cook CC, Scannell TD, Lipsedge MS.","Lancet. 1988 Mar 5;1(8584):524-5. doi: 10.1016/s0140-6736(88)91309-8.","Cook CC","Lancet","1988","1988/03/05","","","10.1016/s0140-6736(88)91309-8"
"2879913","Two stereoisomeric imidazoline derivatives: synthesis and optical and alpha 2-adrenoceptor activities","Biedermann J, León-Lomelí A, Borbe HO, Prop G.","J Med Chem. 1986 Jul;29(7):1183-8. doi: 10.1021/jm00157a011.","Biedermann J","J Med Chem","1986","1986/07/01","","","10.1021/jm00157a011"
"2867050","Pharmacological advances in addiction treatment","Preston KL, Bigelow GE.","Int J Addict. 1985 Jun-Jul;20(6-7):845-67. doi: 10.3109/10826088509047756.","Preston KL","Int J Addict","1985","1985/06/01","","","10.3109/10826088509047756"
"2622999","Differential effects of clonidine analogs on food intake in rabbits and monkeys","Katz NL, Sobaski N, Sanchez J, Young JE, Schlemmer RF Jr.","Pharmacol Biochem Behav. 1989 Oct;34(2):433-7. doi: 10.1016/0091-3057(89)90339-0.","Katz NL","Pharmacol Biochem Behav","1989","1989/10/01","","","10.1016/0091-3057(89)90339-0"
"2576279","Inhibition of adenylate cyclase in bovine ciliary process and rabbit iris ciliary body to alpha 2-adrenergic agonists","Jin Y, Elko EE, Tran T, Yorio T.","J Ocul Pharmacol. 1989 Fall;5(3):189-97. doi: 10.1089/jop.1989.5.189.","Jin Y","J Ocul Pharmacol","1989","1989/01/01","","","10.1089/jop.1989.5.189"
"2568765","Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment","Cushman P Jr, Sowers JR.","Alcohol Clin Exp Res. 1989 Jun;13(3):361-4. doi: 10.1111/j.1530-0277.1989.tb00336.x.","Cushman P Jr","Alcohol Clin Exp Res","1989","1989/06/01","","","10.1111/j.1530-0277.1989.tb00336.x"
"2442539","Rapid eye movement sleep and the associated cardiovascular changes during and after continuous 10-day infusion of clonidine in normotensive rats: comparison with lofexidine and S3341","Lewis SJ, Jarrott B, Doyle AE.","J Cardiovasc Pharmacol. 1987 Jun;9(6):711-8. doi: 10.1097/00005344-198706000-00012.","Lewis SJ","J Cardiovasc Pharmacol","1987","1987/06/01","","","10.1097/00005344-198706000-00012"
"1357064","Effects of lofexidine, an alpha 2-adrenoreceptor agonist, on ocular blood flow and ion transport of rabbit iris-ciliary body","Jin Y, Verstappen A, Elko E, Cammarata P, Yorio T.","J Ocul Pharmacol. 1992 Spring;8(1):23-33. doi: 10.1089/jop.1992.8.23.","Jin Y","J Ocul Pharmacol","1992","1992/01/01","","","10.1089/jop.1992.8.23"
"1352646","Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition","Buccafusco JJ, Li W.","Res Commun Chem Pathol Pharmacol. 1992 Jan;75(1):85-98.","Buccafusco JJ","Res Commun Chem Pathol Pharmacol","1992","1992/01/01","","",""
